Stauffer, Eva-Maria http://orcid.org/0000-0003-2904-5555
Bethlehem, Richard A. I. http://orcid.org/0000-0002-0714-0685
Dorfschmidt, Lena http://orcid.org/0000-0002-0447-1104
Won, Hyejung http://orcid.org/0000-0003-3651-0566
Warrier, Varun http://orcid.org/0000-0003-4532-8571
Bullmore, Edward T.
Article History
Received: 6 April 2023
Accepted: 14 November 2023
First Online: 28 November 2023
Competing interests
: E.T.B. has consulted for GlaxoSmithKline, SR One, Boehringer Ingelheim, Sosei Heptares, and Monument Therapeutics. R.A.I.B. and E.T.B. are directors of and hold stock in CentileBio. All other authors declare no conflicts of interest.